| Application no. and date | 17805885.5 (espacenet) (Federated) (European Patent Register), 20170602 | | Patent/reg. no. and date | DK/EP 3463298, 20210901 | | Publication date | 20190410 | | Priority no. and date | US 201662344660 P, 20160602 | | EP pub. no. and date |
EP 3463298 20190410 | | Effective date | | | Applicant/owner | Innopharmax, Inc., 9F., No.22, Lane 478
Rueiguang Rd.
Neihu District
Taipei City 11492, TW | | Applicant ref. no. | P6122DKEP | | Inventor | HAO, Wei-Hua, 9F. No.22 Lane 478 Rueiguang Rd.
Neihu District
Taipei 11492
Taiwan, TW,
HSUEH, Shu-Piing, 9F. No.22 Lane 478 Rueiguang Rd.
Neihu District
Taipei 11492
Taiwan, TW,
HSU, Chang-Shan, 9F. No.22 Lane 478 Rueiguang Rd.
Neihu District
Taipei 11492
Taiwan, TW | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 47/10 (2017.01) , A61K 47/14 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/107 (2006.01) , A61K 9/48 (2006.01) , A61P 35/00 (2006.01) | | Title | Metronomisk oral gemcitabin til cancerterapi | | Int. application no. | CN2017086942 | | Int. publication no. | WO2017206940 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
